Page last updated: 2024-08-25

dauricine and Breast Cancer

dauricine has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, XD; Zhou, KY; Zhou, X1
Li, CY; Liang, AH; Sun, AX; Wang, JH; Wang, L; Xue, BY; Ye, ZG1

Other Studies

2 other study(ies) available for dauricine and Breast Cancer

ArticleYear
Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:5

    Topics: Angiogenesis Inhibitors; Benzylisoquinolines; Breast Neoplasms; Cell Line; Cell Line, Tumor; Endothelial Cells; Female; Humans; Hypoxia-Inducible Factor 1; Insulin-Like Growth Factor I; Pregnancy; Protein Synthesis Inhibitors; Signal Transduction; Tetrahydroisoquinolines; Transcriptional Activation; Umbilical Veins; Vascular Endothelial Growth Factor A

2009
[Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrug-resistant cells].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2001, Volume: 36, Issue:2

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Isoquinolines; Tetrahydroisoquinolines; Tumor Cells, Cultured; Vincristine

2001